Literature DB >> 11730121

Attitudes of primary care physicians toward cancer-prevention trials: a focus group analysis.

S M Frayne1, M Mancuso, M N Prout, K M Freund.   

Abstract

PURPOSE: Recruitment of low-income and minority women to cancer-prevention trials requires a joint effort from specialists and primary care providers. We sought to assess primary care providers' attitudes toward participating in cancer-prevention trial recruitment. PROCEDURES: We conducted a focus group with seven Boston-based primary care providers serving low-income and minority women. Providers discussed knowledge, attitudes, and beliefs regarding their role in recruitment to prevention trials.
FINDINGS: A qualitative analysis of the focus group transcript revealed nine categories. Three categories related specifically to the primary care physician: 1) the dual role physicians play as advocates for both patient and research; 2) threats to maintaining the primary care relationship; and 3) general philosophy toward prevention. An additional six categories could be subdivided as they apply to the primary care physician, the patient, and the community: 4) trust/commitment; 5) benefits of the research; 6) access to the research; 7) knowledge and recall of the research; 8) influences of media coverage about the research; and 9) cultural sensitivity.
CONCLUSIONS: Investigators conducting cancer-prevention trials must address the concerns of primary care physicians to optimize recruitment of subjects- especially low-income and minority women-into trials.

Entities:  

Mesh:

Year:  2001        PMID: 11730121      PMCID: PMC2594001     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  23 in total

1.  Is there still too much extrapolation from data on middle-aged white men?

Authors:  P Cotton
Journal:  JAMA       Date:  1990-02-23       Impact factor: 56.272

2.  The generalist role of specialty physicians: is there a hidden system of primary care?

Authors:  R A Rosenblatt; L G Hart; L M Baldwin; L Chan; R Schneeweiss
Journal:  JAMA       Date:  1998-05-06       Impact factor: 56.272

3.  The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation.

Authors:  G Corbie-Smith
Journal:  Am J Med Sci       Date:  1999-01       Impact factor: 2.378

Review 4.  Qualitative research in medicine and health care: questions and controversy.

Authors:  R M Poses; A M Isen
Journal:  J Gen Intern Med       Date:  1998-01       Impact factor: 5.128

5.  Representation of American blacks in clinical trials of new drugs.

Authors:  C K Svensson
Journal:  JAMA       Date:  1989-01-13       Impact factor: 56.272

6.  Barriers to black women's participation in cancer clinical trials.

Authors:  C P Mouton; S Harris; S Rovi; P Solorzano; M S Johnson
Journal:  J Natl Med Assoc       Date:  1997-11       Impact factor: 1.798

Review 7.  Recruitment experience in clinical trials: literature summary and annotated bibliography.

Authors:  D B Hunninghake; C A Darby; J L Probstfield
Journal:  Control Clin Trials       Date:  1987-12

8.  Recruiting elderly African-American women in cancer prevention and control studies: a multifaceted approach and its effectiveness.

Authors:  K Zhu; S Hunter; L J Bernard; K Payne-Wilks; C L Roland; R S Levine
Journal:  J Natl Med Assoc       Date:  2000-04       Impact factor: 1.798

9.  The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS).

Authors:  P B Gorelick; Y Harris; B Burnett; F J Bonecutter
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

10.  Provider attitudes regarding participation of women and persons of color in AIDS clinical trials.

Authors:  V E Stone; M Y Mauch; K A Steger
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-11-01
View more
  8 in total

1.  CSHCN in Texas: meeting the need for specialist care.

Authors:  M Cherilyn Young; Vonna L C Drayton; Ramdas Menon; Lesa R Walker; Colleen M Parker; Sam B Cooper; Linda L Bultman
Journal:  Matern Child Health J       Date:  2005-06

2.  Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis.

Authors:  Nicola Farrar; Daisy Elliott; Catherine Houghton; Marcus Jepson; Nicola Mills; Sangeetha Paramasivan; Lucy Plumb; Julia Wade; Bridget Young; Jenny L Donovan; Leila Rooshenas
Journal:  Trials       Date:  2022-10-20       Impact factor: 2.728

3.  Recruiting low-income healthy women to research: an exploratory study.

Authors:  Galen Joseph; Celia P Kaplan; Rena J Pasick
Journal:  Ethn Health       Date:  2007-11       Impact factor: 2.772

4.  Increasing primary care physician support for and promotion of cancer clinical trials.

Authors:  M Koa Robinson; Joann U Tsark; Kathryn L Braun
Journal:  Hawaii J Med Public Health       Date:  2014-03

5.  Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).

Authors:  Raegan W Durant; Jennifer A Wenzel; Isabel C Scarinci; Debora A Paterniti; Mona N Fouad; Thelma C Hurd; Michelle Y Martin
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860

6.  Guideline implementation in the Canadian chiropractic setting: a pilot cluster randomized controlled trial and parallel study.

Authors:  Prakash Dhopte; Simon D French; Jeffrey A Quon; Heather Owens; André Bussières
Journal:  Chiropr Man Therap       Date:  2019-07-17

7.  Researchers' and clinicians' perceptions of recruiting participants to clinical research: a thematic meta-synthesis.

Authors:  Lisa Newington; Alison Metcalfe
Journal:  J Clin Med Res       Date:  2014-03-31

8.  Specialist nurses' perceptions of inviting patients to participate in clinical research studies: a qualitative descriptive study of barriers and facilitators.

Authors:  Caroline French; Charitini Stavropoulou
Journal:  BMC Med Res Methodol       Date:  2016-08-11       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.